Ocugen (OCGN) filed a registration statement Friday for the sale of up to 57.5 million shares by selling stockholders.

The prospectus includes 56.5 million common shares issuable on conversion of notes for up to $6 million outstanding principal amount of notes and 1.1 million shares issued to lenders in a private placement, the company added.

Ocugen said it will not receive any proceeds from the sale of shares by selling stockholders.

Shares were up nearly 2% in recent after-hours activity.